© 2008 European Society of Cardiology
Telomere biology in heart failure
a Department of Cardiology, University Medical Center Groningen, University of Groningen Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
b Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester Leicester, United Kingdom
* Corresponding author. Tel.: +31 503612355; fax: +31 503614391. E-mail address: p.van.der.harst{at}thorax.umcg.nl (P. van der Harst)
| Abstract |
|---|
The incidence and prevalence of cardiovascular disease increases progressively with advancing age. Cardiovascular disease is a major cause of morbidity and mortality in Western Countries. In the near future, as the population ages, it is expected that the population prevalence of cardiovascular disease will increase dramatically, imposing a major social and economical burden on society. Not only is age closely related to the development and progression of cardiovascular disease, but genetic and environmental factors also play an important role. Recently, a chromosomal mechanism, telomere shortening, has been considered a driving force by which genetic and environmental factors jointly affect biological aging, and possibly the risk for developing age-associated diseases. Telomeres are the extreme ends of chromosomes and shorten progressively during every cell cycle and therefore can be considered an indicator of biological age. In heart failure, telomere length is severely reduced. In the current review, we will discuss the emerging role of telomere biology in the pathophysiology of heart failure.
Key Words: Telomeres Telomerase Heart failure Atherosclerosis Diabetes Review
Received December 8, 2007; Revised May 27, 2008; Accepted August 14, 2008
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. van der Harst, R. A. de Boer, and D. J. van Veldhuisen The Nobel Prize for medicine for telomere biology and relevance to heart failure research Eur J Heart Fail, December 1, 2009; 11(12): 1113 - 1115. [Full Text] [PDF] |
||||
![]() |
U. Sennerby, H. Melhus, R. Gedeborg, L. Byberg, H. Garmo, A. Ahlbom, N. L. Pedersen, and K. Michaelsson Cardiovascular Diseases and Risk of Hip Fracture JAMA, October 21, 2009; 302(15): 1666 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing Cardiovasc Res, February 1, 2009; 81(2): 244 - 252. [Abstract] [Full Text] [PDF] |
||||


